Zimmer Biomet (ZBH) director reports 304 new phantom stock units

Rhea-AI Filing Summary

Zimmer Biomet Holdings, Inc. director Arthur J. Higgins reported changes in his deferred compensation holdings. On 12/31/2025 he acquired 304.439 phantom stock units under the company’s Deferred Compensation Plan for Non-Employee Directors, which are tied 1-for-1 to shares of common stock. These units are scheduled to be settled in cash in ten annual installments after his service as a director ends, beginning within sixty days after the end of the calendar year in which his board service ceases.

Following this transaction, Higgins beneficially owned 35,967.099 phantom stock units. This total includes 85.437 phantom stock units that were previously accrued on October 31, 2025 under the plan’s dividend reinvestment provision.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HIGGINS ARTHUR J

(Last) (First) (Middle)

345 E. MAIN STREET

(Street)

WARSAW IN 46580

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units(1)	$90.33(2)	12/31/2025		A		304.439		(3)	(3)	Common Stock	304.439	$0	35,967.099(4)	D

Explanation of Responses:

1. The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

2. The Conversion or Exercise Price of Derivative Security is 1-for-1.

3. Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

4. Includes 85.437 phantom stock units accrued on October 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

	/s/ Matthew R. St. Louis, Attorney-in-Fact for Arthur J. Higgins (power of attorney previously filed)	01/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity at ZBH does this Form 4 report for Arthur J. Higgins?

The filing reports that director Arthur J. Higgins acquired 304.439 phantom stock units of Zimmer Biomet Holdings, Inc. on 12/31/2025 under the Deferred Compensation Plan for Non-Employee Directors.

What are the key terms of Arthur J. Higgins’ phantom stock units at Zimmer Biomet (ZBH)?

The phantom stock units have a 1-for-1 conversion or exercise price relative to Zimmer Biomet common stock and are to be settled in cash in ten annual installments beginning within sixty days after the end of the calendar year in which his service as a director ends.

How many Zimmer Biomet (ZBH) phantom stock units does Arthur J. Higgins hold after this transaction?

After the reported transaction, Arthur J. Higgins beneficially owned 35,967.099 phantom stock units related to Zimmer Biomet common stock.

How were dividend reinvestments treated in Arthur J. Higgins’ ZBH phantom stock account?

His holdings include 85.437 phantom stock units that were accrued on October 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Does this Zimmer Biomet (ZBH) Form 4 involve direct stock or only derivative securities?

The disclosed transaction involves derivative securities in the form of phantom stock units linked to Zimmer Biomet common stock, reported in Table II of the filing.